Gastrografin
Gastrografin is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Optimizing Treatment of Adhesive Small Bowel Obstruction
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.
The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel Obstruction
Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants
Clinical Trials (7)
Optimizing Treatment of Adhesive Small Bowel Obstruction
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.
The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel Obstruction
Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants
Study of the Effect of Water Soluble Oral Contrast (Gastrografin) on Postoperative Ileus After Colorectal Surgery
Gastrografin in Postoperative Ileus
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7